Value-based care (VBC) has moved well beyond experimentation. For many healthcare organizations, value-based contracts now represent a significant share of revenue, risk exposure, and strategic focus. The industry has largely resolved the question of whether to participate in these models. What remains unresolved is how to manage them most effectively.
Increasingly, a common source of failure in VBC is not poor clinical performance or lack of commitment, but rather a gap in availability of reliable financial reporting throughout the year. In many organizations, operational teams track utilization and quality trends, but these insights aren’t translated into contract-specific financial projections. Reconciliation becomes the first moment when all the pieces come together into a single, authoritative view.
This creates a narrow window for learning and intervention. Opportunities to course-correct are missed because emerging gaps surface too late. Leaders hesitate to invest in care coordination or staffing without confidence in financial trajectory. End-of-year surprises erode confidence in VBC, even when clinical performance is strong. Many organizations are discovering, too late, whether their value-based contracts are actually generating savings.
The real bottleneck: financial insight that arrives too late
Much of the industry conversation around VBC continues to focus on risk exposure — one-sided versus two-sided arrangements, attribution methodologies, and benchmark construction. These decisions matter, particularly as organizations take on greater downside exposure. But once a baseline level of VBC maturity is reached, they explain less and less of the performance variation we see in practices.
A common failure mode today is quieter and more operational. Contracts appear to be performing well during the year. Leaders reasonably expect positive outcomes based on the signals they can see. Then reconciliation arrives, and the numbers tell a different story. By that point, the opportunity to intervene has passed.
Value-based contracts are inherently complex. Benchmarks evolve as attribution changes. Risk adjustment lags behind clinical reality. Payer reporting schedules vary and often trail real-world activity by months. These dynamics make mid-year performance difficult to interpret, even for experienced teams. Without actuarially sound modeling of those contract mechanics, performance can look encouraging operationally while remaining financially uncertain.
This pattern has become common enough to warrant a reframing of the problem. Organizations are not failing in VBC because they chose the wrong contract type or took too much risk. They are failing because reliable financial insight arrives too late in the year to influence the outcome.
What high-performing ACOs do differently
High-performing ACOs approach value-based contracts as evolving financial arrangements, not static agreements evaluated at year end. While their contract portfolios vary, what distinguishes these organizations is how early and confidently they understand financial performance while the year is still unfolding.
Rather than waiting for reconciliation to confirm results, these organizations forecast performance consistently throughout the year using benchmarks that evolve as attribution, risk adjustment, and utilization change. The goal is not precision for its own sake, but directional clarity, knowing early whether a contract is trending toward savings or risk, and how quickly that trajectory is changing.
They also draw a clear line between operational performance and financial outcomes. Improvements in utilization, quality, or post-acute patterns are evaluated in the context of specific contracts, not in aggregate. This allows leaders to prioritize interventions that meaningfully influence financial results, instead of treating all performance improvements as equally urgent.
In these organizations, financial projections are not a year-end exercise but an ongoing discipline. Regular comparison of internal projections to payer-reported results surfaces discrepancies earlier, reduces disputes, and builds trust in the numbers long before settlement. Over time, this discipline replaces surprise with confidence.
Most importantly, high-performing ACOs govern value-based contracts differently. Ownership of financial performance is explicit. Escalation paths are clear. Decisions about investment, intervention, or restraint are informed by timely insight rather than retrospective explanation.
Recent MSSP experience reinforces these patterns. In 2024, more than 60% of MedInsight-supported ACOs increased their savings compared to the prior year and savings per beneficiary among these organizations exceeded national averages. The highest performers in this cohort were distributed across contract types and risk models. What they shared more consistently was close attention to where each contract stood financially, tracked through the year rather than assessed only at its close. This challenges the assumption that success is primarily a function of contract design. Instead, it points to a different conclusion. For organizations past the early stages of VBC adoption, this experience points to a shift in where the practical constraint lies. Financial clarity during the year may carry as much weight as the terms of the contract itself.
Forecasting as a financial governance requirement
Forecasting is often discussed as a technical capability owned by analytics or finance teams. In practice, its role is much broader. Effective forecasting supports financial governance.
It informs leadership decisions about where to invest, which contract requires attention, and how to allocate resources across populations. It enables contract leaders to validate payer results with confidence. It provides a shared understanding of performance across clinical, operational, and financial teams.
For forecasting to serve that governance role, it has to be grounded in how contracts are actually settled. Trending utilization or extrapolating last year’s results can be informative, but it is not enough to support accountability. Decision-grade forecasting requires transparent assumptions, consistent treatment of contract terms, and actuarially credible methods that tie projections back to benchmark construction and settlement rules, the same logic that ultimately determines shared savings. Without that discipline, forecasts remain approximations, useful for discussion, but insufficient for acting with confidence.
Without this capability, organizations default to managing value-based contracts through hindsight. Decisions become cautious. Investments are delayed. Accountability becomes blurred. Forecasting does not need to be perfect to be useful, but it does need to be credible, transparent, and timely enough to support action.
The next phase of value-based care maturity
VBC is no longer optional for many healthcare organizations. The question is no longer whether to take risk. The more relevant question is whether leaders know, early enough, if their contracts are on track, and whether they trust that answer.
Organizations that can answer that question with confidence are better positioned to manage both upside and downside exposure. They replace late-stage explanation with earlier understanding. They shift from reacting to results to influencing them.
This represents the next phase of VBC maturity. It is not defined by contract sophistication or analytics volume, but by financial certainty delivered in time to matter.
Supporting financial certainty with MedInsight
Milliman MedInsight solutions are designed to support this shift toward earlier, more defensible financial insight. Built on Milliman’s actuarial methodologies, this approach helps ensure that mid-year projections and reconciliation logic align with how value-based contracts are actually measured and settled. The MedInsight VBC Platform brings together cost, utilization, quality and attribution insights, providing a shared foundation for understanding performance across teams. VBC Contracts enables organizations to monitor performance against contract-specific benchmarks as they evolve, supporting earlier awareness of emerging risk and opportunity.
Together, these capabilities help organizations move from retrospective assessment to proactive financial management, turning value-based contracts into manageable, predictable components of the operating model.
